Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Income towards Parent Company (2018 - 2025)

Historic Income towards Parent Company for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to -$4.8 million.

  • Dna X's Income towards Parent Company fell 8921.18% to -$4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.0 million, marking a year-over-year decrease of 16253.66%. This contributed to the annual value of -$34.3 million for FY2024, which is 1033701.49% down from last year.
  • Dna X's Income towards Parent Company amounted to -$4.8 million in Q3 2025, which was down 8921.18% from -$7.5 million recorded in Q2 2025.
  • Dna X's 5-year Income towards Parent Company high stood at $527000.0 for Q3 2023, and its period low was -$22.3 million during Q4 2024.
  • In the last 5 years, Dna X's Income towards Parent Company had a median value of -$4.2 million in 2022 and averaged -$5.2 million.
  • As far as peak fluctuations go, Dna X's Income towards Parent Company soared by 13277.36% in 2023, and later crashed by 229870.69% in 2024.
  • Over the past 5 years, Dna X's Income towards Parent Company (Quarter) stood at -$11.7 million in 2021, then soared by 89.91% to -$1.2 million in 2022, then grew by 21.69% to -$928000.0 in 2023, then tumbled by 2298.71% to -$22.3 million in 2024, then soared by 78.65% to -$4.8 million in 2025.
  • Its Income towards Parent Company was -$4.8 million in Q3 2025, compared to -$7.5 million in Q2 2025 and $458000.0 in Q1 2025.